The molecular cloning of telomerase and telomere components has enabled the analysis and precise manipulation of processes that regulate telomere length maintenance. In mammalian cells and in other organisms, we now recognize that disruption of telomere integrity via any one of a number of perturbations induces chromosome instability and the activation of DNA damage responses. Thus, telomere dysfunction may represent a physiological trigger of the DNA damage or apoptotic response in an analogous fashion to other genotoxic insults that introduce chromosome breaks. Initial studies in mice lacking the murine telomerase RNA and in cells expressing a dominant negative version of the telomere binding protein TRF2 revealed a strong p53-dependent response to telomere dysfunction. Yet, telomere dysfunction exhibits p53-independent eects as well, an observation supported by p53-independent responses to telomere dysfunction in p53 mutant human tumor cell lines and mouse cells. As most tumors are compromised for p53 function, examination of this p53-independent response warrants closer attention. A better understanding of this p53-independent response may prove critical for determining the ultimate utility of telomerase inhibitors in the clinic. This review will summarize our current understanding of the molecular responses to telomere dysfunction in mammalian cells.
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Protective function of telomeres
Maintenance of functional telomeres at chromosome ends is required for the prolonged survival of most organisms with linear chromosomes. Telomeres serve to limit the loss of genetic material from chromosome ends that is thought to occur due to incomplete DNA replication, thus protecting chromosome ends from recombination and fusion. In most eukaryotes, the replenishment of telomere DNA is carried out by a ribonucleoprotein reverse transcriptase called telomerase (Greider, 1996) . In mammalian cells, a strong correlation between telomere length and replicative potential in vivo has led to the telomere hypothesis (Harley, 1991 (Harley, , 1996 . This postulate states that, in cells without telomerase activity, loss of telomere DNA eventually triggers a cellular response, perhaps via a DNA damage response, that leads to growth arrest or apoptosis. This hypothesis is supported in part by the observation that ectopically introduced telomerase activity can extend telomeres and inde®nitely prolong cellular lifespan (Bodnar et al., 1998; Vaziri and Benchimol, 1998) . In addition to telomere attrition, more recent experiments suggest that telomere deprotection can also be induced by the loss of function of double stranded telomere binding proteins at the telomere. In this case, telomere deprotection occurs rapidly, and without a concomitant loss in telomere DNA van Steensel et al., 1998) . Inhibition of the double stranded telomere binding protein TRF2 also leads to loss of the 3' single-stranded G overhang at telomeres (van Steensel et al., 1998) . Loss of this overhang is thought to perturb the ability of telomere DNA and its associated binding proteins to form a speci®c looped structure called a t-loop (Grith et al., 1999) (Figure 1 ). Whether induced by telomere attrition or generated through disruption of telomere structure, the loss of telomere protection is commonly referred to as telomere dysfunction.
The requirement for a functional telomere is thought to be particularly relevant in cancer. Tumor cells, which likely undergo more cell divisions than their normal cellular counterparts, often possess shortened telomeres (de Lange et al., 1990; Engelhardt et al., 1997 Engelhardt et al., , 1998 Hastie et al., 1990) . The observation that 90% of tumors exhibit telomerase activity (Shay and Bacchetti, 1997) suggests that tumor cells preferentially utilize telomerase to maintain telomeres and thus retain their proliferative potential. Understanding the cellular response to telomere dysfunction may enable a greater understanding of the role of telomeres in chromosomal stability and, from a clinical perspective, may facilitate the design of agents that selectively disrupt telomere integrity in tumor cells. The recent molecular cloning and characterization of telomere and telomerase components has facilitated our understanding of how cells maintain telomere function, and how they respond to telomere dysfunction.
from following the fate of SV40-transformed human embryonic kidney cells (Counter et al., 1992) . At the onset of`crisis', most cells exhibited genome instability and died, but rare cells (1 in 10 7 ) that overcame this hurdle acquired telomerase activity, and could divide inde®nitely in culture. Immortalized cells are thought to avoid telomere dysfunction by either the activation of endogenous telomerase activity, or other rarer alternative means of telomere length maintenance (referred to as ALT) (Bryan et al., 1997; Dunham et al., 2000) . More direct support for the role of telomere length maintenance in cell survival was aorded by the introduction of hTERT into primary human cells that already contain the telomerase RNA. Primary cells reconstituted with telomerase divide inde®nitely, apparently without acquisition of genome instability (Bodnar et al., 1998; Morales et al., 1999; Vaziri and Benchimol, 1998; Vaziri et al., 1999) . However, in the added presence of SV40 large T and small T antigens and oncogenic ras, hTERT transformed ®broblasts do become tumorigenic (Hahn et al., 1999a) .
mTerc knockout mice
The molecular cloning of the murine telomerase RNA in 1995 (Blasco et al., 1995) enabled Greider, DePinho and colleagues to use knockout technology to examine the consequences of telomere loss in laboratory mouse strains. These experiments initially revealed that telomerase function was not required for normal murine growth and development (Blasco et al., 1997) . However, after breeding successive generations of telomerase-de®cient mice, multiple phenotypes were uncovered, including defects in cell proliferation, wound healing, and most notably the apoptotic loss of spermatogonia resulting in sterility (Lee et al., 1998; Rudolph et al., 1999) . The germ line apoptosis was dependent on p53, as the genetic removal of p53 Figure 1 Model for possible responses to telomere dysfunction. At top left, a representation of some of the components associated with the mammalian telomere depicted as a terminal t-loop. At top right, a representation of the telomerase enzyme. Disruption of telomeric structure (left) or telomerase inhibition (right) leads to deprotection of telomeres referred to as telomere dysfunction. Telomeric structure disruption results in rapid induction of telomere dysfunction, whereas loss of telomerase activity requires telomere erosion to initiate telomere dysfunction. Telomere dysfunction is recognized by both p53 dependent and p53 independent mechanisms, although p53 independent recognition may require additional damage prior to response. While the exact pathway that induces apoptosis under either scenario is not yet known, it is possible that both the p53-dependent and p53-independent responses may share downstream signaling components with each other, and in common with other types of genotoxic stress or DNA damage. See text for details and references restored fertility to these animals for a few additional generations (Chin et al., 1999) . Furthermore, late generation mice lacking both telomerase activity and p53 exhibited an increased incidence of cancer relative to animals lacking only mTerc Rudolph et al., 2001) . The observation that p53 loss could forestall germ cell apoptosis in these animals, and the increased incidence of tumors in p53 (7/7) mTerc (7/7) mice de®ned p53 as a key regulator of the response to telomere dysfunction. However, p53 (7/7) mTerc (7/7) mice progressed only a few more generations before again becoming sterile, thus de®ning a second, p53-independent block to cell viability (Chin et al., 1999) . Although not characterized in detail, the eventual loss of cell viability in mTerc (7/7) p53 (7/7) mice was considered to result from genetic catastrophe ± the accumulation of sucient genetic damage to render a cell unable to perform basic functions required for viability (Chin et al., 1999) . These experiments parallel the p53 dependent and independent blocks to proliferation in human diploid ®broblasts, and genetically de®ne both p53 dependent and independent responses to telomere dysfunction.
Telomere binding protein disruption
A separate pathway to telomere dysfunction, that of inhibiting the function of double-stranded telomere binding factors, can also lead to a p53-dependent, apoptotic or cell arrest response. In mouse embryo ®broblasts and human HeLa, MCF-7, and immortalized B cell lines, enforced expression of a dominant negative version of the telomere binding protein TRF2 (DNTRF2) resulted in the rapid induction of apoptosis . Mouse embryonic ®broblasts that lacked p53 (or human AT-de®cient B cell lines) failed to undergo apoptosis in response to DNTRF2 overexpression . In one of these experiments , careful analysis of the timing of apoptosis demonstrated that recognition of telomere dysfunction could occur rapidly and without the need for DNA replication. In another experiment, (van Steensel et al., 1998) overexpression of DNTRF2 in p53 mutant, human immortalized (HT1080) cells led to rapid chromosomal fusions followed by cell arrest. These results further support the notion that the response to telomere dysfunction has both p53 dependent and p53 independent components.
Telomerase inhibition
Mutation of essential residues within the reverse transcriptase motifs of TERT abolish telomerase activity (Beattie et al., 1998; Harrington et al., 1997; Lingner et al., 1997; Nakayama et al., 1998; Weinrich et al., 1997) and overexpression of these mutant TERT proteins in telomerase-positive cells act as dominant negative proteins to suppress activity. Several experiments have now been performed in human tumor cell lines using either constitutive (Colgin et al., 2000; Guo et al., 2001; Hahn et al., 1999b; Yi et al., 2000) or inducible ) expression of dominant negative TERT (DNTERT) proteins. Together, these experiments showed that even p53 de®cient human cell lines could suer telomere attrition and undergo apoptosis or arrest (Table 1) . Hahn, Stewart and colleagues (Hahn et al., 1996b ) demonstrated a correlation between telomere length and time to apoptosis, suggesting that telomere maintenance and not telomerase activity per se was critical for survival. By using an inducible system for DNTERT overexpression, we showed that telomerase inhibition occurred rapidly, followed by chromosome fusion, followed soon after by upregulation of DNA damage response genes, and ®nally resulting in induction of apoptosis throughout the entire population (Zhang et al., 1999 and our unpublished results) . Importantly, overexpression of active TERT, which diered from the DNTERT by one amino acid, did not elicit these responses . These experiments are also supported by work utilizing either modi®ed oligonucleotides (Herbert et al., 1999) or ribozyme constructs (Ludwig et al., 2001 ) to block telomerase activity. Using RNA template complementary oligonucleotides, Herbert et al. (1999) performed repeated transfections of such oligos in human cell lines to inhibit telomerase, causing telomere shortening and apoptosis (Table 1) . Ludwig et al. (2001) used both transfection and infection of ribozyme based TERT inhibitors to the same eect in human breast epithelial cell lines. All of these approaches to inhibit telomerase activity yielded similar results. Independent of p53 status, telomerase inhibition in these models led to telomere dysfunction and in almost all cases, cell death or cell arrest. It is not clear whether cell lines with an intact p53 response respond more rapidly than those without; such a determination may require the engineering of a conditional p53 allele into the appropriate cell line.
Examining these data as a whole, one observes a general trend between initial telomere length and time to loss of viability (Table 1) . Furthermore, most of the cell lines with initially short telomeres (A431, MCF7, Lovo, HME50-5E) exhibited apoptosis within 20 population doublings (PD) or less, independent of p53 status. One potential concern for telomerase inhibition therapy would be the lag period required for obtaining a critically short telomere length. Provided the above experiments have predictive value, tumors with short telomeres might be eectively and rapidly eliminated using telomerase inhibitors. Carefully designed clinical studies incorporating telomere length measurements may prove bene®cial in determining which tumor subsets may be likely to respond to such inhibitors. One other potential concern is the ability of human tumors to circumvent telomerase inhibition by the induction of alternate, recombinationbased means of telomere length maintenance. Although evidence of the ALT pathway was not noted in the experiments summarized in Table 1 , additional experiments will be required to determine if prolonged inhibition of telomerase selects for cells that employ alternate means of telomere length maintenance.
Mutant telomerase RNA
Yet another approach to induce telomere dysfunction also yielded results similar to those summarized above. This approach relied on the expression of mutant telomerase RNA (TERC) molecules (Guiducci et al., 2001; Kim et al., 2001; Marusic et al., 1997) . When constructs expressing TERC molecules mutated in the template region were expressed in mammalian cells, they could be complex, with endogenous hTERT and result in the incorporation of the mutant sequence into chromosomal telomeres. The incorporation of mutant telomeric repeats is expected to disrupt the binding of telomere repeat binding factors such as TRF1 and TRF2, as these proteins preferentially recognize the wild-type TTAGGG sequence (Broccoli et al., 1997; Chong et al., 1995) . In these experiments, the loss of viability was rapid and did not correlate with telomere shortening, consistent with the hypothesis that disruption of telomere protection via the telomere binding proteins may elicit a rapid, DNA damage-like response. In these studies, cells containing both wild-type p53 (MCF7, LNCap (Kim et al., 2001) ) and mutant p53 (HT1080, SUSM-1, VA13 (Guiducci et al., 2001; Marusic et al., 1997) ) showed similar eects. These studies further support the notion that the loss of viability induced by telomere dysfunction is not dependent on a functional p53 response.
Overlapping or redundant pathways respond to telomere dysfunction
Consistent with early predictions, it appears that telomere dysfunction shows some parallels with the DNA damage response. For example, cells that failed to die in response to DNTRF2 overexpression appeared to lack either p53 or a more general apoptotic response to DNA damage . In mammals, the initial response to telomere dysfunction may thus occur via a p53-dependent pathway, which may provide an early monitor of genomic instability. In some instances, this response can be rapid and can occur without additional cell proliferation. However, in all of these experimental paradigms there also exists a p53 independent response, for example in mTerc (7/7) p53 (7/7) germ cells, p53 null HT1080 cells, and SV40 T antigen transformed human primary cells. In addition, human tumor derived cell lines succumb to telomerase inhibition independent of their p53 status. The p53-independent response may result from continued cell division and accumulation of additional DNA damage, possibly triggered by the breakage of telomere/telomere fusions that are observed in TRF2DN HT1080 cells, This number re¯ects the data presented by the authors + 20 PD, our estimate of the number of doublings required to reach con¯uence in a 10 cm dish. PD: population doubling. ND: not determined mTerc (7/7) p53 (7/7) cells and p53 mutant tumor cell lines.
Based on the data summarized above, we suggest that, in addition to the p53 dependent response, the p53 independent response to telomere dysfunction is also a speci®c, programmed response. For example, not all cell types appear to be competent to induce apoptosis or cell arrest in response to telomerase inhibition . In 293T cells, telomerase inhibition does not lead to apoptosis, and the cells eventually recover by the reactivation of endogenous telomerase . It is possible that this cell type has lost some component of the p53-independent response to telomere dysfunction, or perhaps is inherently resistant to induction of apoptosis under certain conditions. In order to understand the molecular basis of this eect, we used microarray analysis to examine genes whose expression is induced in response to telomerase inhibition (Robinson, unpublished) . Preliminary examination of the molecular response to telomere dysfunction in A431 cells has revealed the activation of genes in the Growth Arrest and DNA Damage (GADD) pathway. The GADD proteins, a group of unrelated proteins that are transcriptionally induced in response to various types of stress, can be induced by both p53 and independently of p53 (e.g. by the p53-like protein p73) (De Laurenzi and Melino, 2000) . Thus, the GADD genes are intriguing candidates for the induction of apoptosis in response to telomere dysfunction. Further experiments are aimed at examining whether inhibition of GADD activation has any consequences for telomere dysfunction and apoptosis in A431 cells, and whether this pathway might be perturbed in 293T cells.
While not discussed here, increasing evidence in budding yeast also suggests that the cell may utilize common`sensor pathways' for both telomere protection and DNA repair and recombination elsewhere in the genome (Kass-Eisler and Greider, 2000) . In mammals, a common emerging theme is that cell division arrest or apoptosis in response to DNA damage can be partially suppressed by loss of p53. In one example reminiscent of the germ cell apoptosis seen in TERC (7/7) mice, embryos lacking the BRCA1 tumor suppressor gene exhibit massive apoptosis early in development, a condition that can be delayed by a few days by germ line removal of p53 (Hakem et al., 1997) . Other experiments examining the combination of telomere dysfunction and genotoxic agents show that these two perturbations elicit an additive or synergistic decrease in cell proliferation or viability (Lee et al., 2001; Ludwig et al., 2001; Wong et al., 2000) . However, in these studies p53 was required for the observed additive eects in two of the experiments, and the third study was carried out in wild-type p53 cell lines. Taken together, these experiments add further support to the postulate that telomere dysfunction may be sensed in a similar fashion to other types of genotoxic stress, via both a p53-dependent and p53 independent sensing mechanisms.
Increasing evidence suggests that many organisms, including mammals, may have evolved a DNA damage-like response in response to a critically short or deprotected telomere. This response may be regulated directly, for example by the TRF2 associated Mre11/Rad50/Nbs1 complex, or indirectly, perhaps through alteration of the t-loop structure . These nucleoprotein structures may play a physiological role in the elongation and replication of the telomere, for example, as a means to prevent a transiently`deprotected' telomere from being recognized as DNA damage during S phase . Furthermore, the importance of this physiologic, protective function may have led to the convergence or duplication of pathways that signal cell arrest or death upon loss of telomere function. Thus, the response to dysfunctional telomeres may be as relevant as irradiation or other more extreme types of genotoxic stress. Dissecting the molecular components of the pathways that become activated upon telomere dysfunction will no doubt provide valuable insight into how cells sense the ®delity of their genetic material, and perhaps lead to therapeutic modalities that, in conjunction with telomerase inhibition, might eciently and selectively kill tumor cells.
